{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:54:49Z","timestamp":1761173689508,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"am","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.purol.2020.04.003","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T07:33:04Z","timestamp":1588318384000},"page":"488-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Traitement de la maladie de Lapeyronie par ondes de choc extracorporelles"],"prefix":"10.1016","volume":"30","author":[{"given":"A.","family":"Ochoa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Guillot-Tantay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Faix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Misrai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2020.04.003_bib0140","doi-asserted-by":"crossref","first-page":"282503","DOI":"10.1155\/2011\/282503","article-title":"A population-based study of Peyronie's disease: prevalence and treatment patterns in the United States","volume":"2011","author":"Dibenedetti","year":"2011","journal-title":"Adv Urol"},{"issue":"6","key":"10.1016\/j.purol.2020.04.003_bib0145","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jsxm.2016.04.062","article-title":"Evidence-based management guidelines on Peyronie's disease","volume":"13","author":"Chung","year":"2016","journal-title":"J Sex Med"},{"issue":"3","key":"10.1016\/j.purol.2020.04.003_bib0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.purol.2013.08.328","article-title":"Medical and surgical treatments of congenital and acquired penile curvatures: a review","volume":"24","author":"Guillot-Tantay","year":"2014","journal-title":"Prog Urol"},{"issue":"3","key":"10.1016\/j.purol.2020.04.003_bib0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","article-title":"EAU guidelines on penile curvature","volume":"63","author":"Hatzimouratidis","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.purol.2020.04.003_bib0160","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2011.02.033","article-title":"Shock wave technology and application: an update","volume":"59","author":"Rassweiler","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2020.04.003_bib0165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jsxm.2017.02.004","article-title":"In situ activation of penile progenitor cells with low-intensity extracorporeal shockwave therapy","volume":"14","author":"Lin","year":"2017","journal-title":"J Sex Med"},{"issue":"8","key":"10.1016\/j.purol.2020.04.003_bib0170","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1464-410X.2008.07742.x","article-title":"Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: a feasibility study and the first clinical results","volume":"102","author":"Zimmermann","year":"2008","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.purol.2020.04.003_bib0175","first-page":"417","article-title":"Possibility of using the piezoelectric lithotriptor in the treatment of severe cavernous fibrosis","volume":"61","author":"Bellorofonte","year":"1989","journal-title":"Arch Ital Urol Nefrol Androl"},{"key":"10.1016\/j.purol.2020.04.003_bib0180","first-page":"159","article-title":"Treatment of Peyronie's disease (PD) by extracorporeal shock waves (ESW)","author":"Butz","year":"1998","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2020.04.003_bib0185","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1464-410X.2000.00827.x","article-title":"Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience","volume":"86","author":"Husain","year":"2000","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.purol.2020.04.003_bib0190","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","article-title":"A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease","volume":"56","author":"Palmieri","year":"2009","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.purol.2020.04.003_bib0195","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1464-410X.2010.09331.x","article-title":"Limited shock wave therapy vs sham treatment in men with Peyronie's disease: results of a prospective randomized controlled double-blind trial","volume":"106","author":"Chitale","year":"2010","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.purol.2020.04.003_bib0200","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1111\/jsm.12275","article-title":"Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study","volume":"10","author":"Hatzichristodoulou","year":"2013","journal-title":"J Sex Med"},{"issue":"3","key":"10.1016\/j.purol.2020.04.003_bib0205","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1745-7262.2006.00138.x","article-title":"Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment\u00a0?","volume":"8","author":"Poulakis","year":"2006","journal-title":"Asian J Androl"},{"issue":"5","key":"10.1016\/j.purol.2020.04.003_bib0210","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0090-4295(02)01970-2","article-title":"Evaluation of extracorporeal shock wave therapy in Peyronie's disease","volume":"60","author":"Manikandan","year":"2002","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.purol.2020.04.003_bib0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4103\/0974-7796.192100","article-title":"Role of extracorporeal shock wave therapy in management of Peyronie's disease: a preliminary report","volume":"8","author":"Shimpi","year":"2016","journal-title":"Urol Ann"},{"issue":"2\u00a0Pt 1","key":"10.1016\/j.purol.2020.04.003_bib0220","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/01.ju.0000108060.30363.8d","article-title":"Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials","volume":"171","author":"Hauck","year":"2004","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2020.04.003_bib0225","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1159\/000020359","article-title":"Extracorporal shock wave therapy in the treatment of Peyronie's disease. First results of a case-controlled approach","volume":"38","author":"Hauck","year":"2000","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2020.04.003_bib0230","first-page":"384","article-title":"Ultrasound-guided ESWT in Peyronie's disease plaques","volume":"72","author":"Mirone","year":"2000","journal-title":"Arch Ital Urol Androl"},{"issue":"5","key":"10.1016\/j.purol.2020.04.003_bib0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ijir.2016.24","article-title":"A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease","volume":"28","author":"Gao","year":"2016","journal-title":"Int J Impot Res"},{"issue":"3","key":"10.1016\/j.purol.2020.04.003_bib0240","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5534\/wjmh.180100","article-title":"Extracorporeal shock wave therapy in Peyronie's disease: clinical efficacy and safety from a single-arm observational study","volume":"37","author":"Di Mauro","year":"2019","journal-title":"World J Mens Health"},{"issue":"5","key":"10.1016\/j.purol.2020.04.003_bib0245","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0090-4295(02)01527-3","article-title":"Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline)","volume":"59","author":"Lebret","year":"2002","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.purol.2020.04.003_bib0250","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.ju.0000099891.68488.4e","article-title":"Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach","volume":"171","author":"Hauck","year":"2004","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2020.04.003_bib0255","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie's disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J Urol"},{"issue":"11","key":"10.1016\/j.purol.2020.04.003_bib0260","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4111\/kju.2015.56.11.775","article-title":"Peyronie's disease and low intensity shock wave therapy: clinical outcomes and patient satisfaction rate in an open-label single arm prospective study in Australian men","volume":"56","author":"Chung","year":"2015","journal-title":"Korean J Urol"},{"issue":"2","key":"10.1016\/j.purol.2020.04.003_bib0265","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.sxmr.2018.09.007","article-title":"Review of management options for active-phase Peyronie's disease","volume":"7","author":"Brimley","year":"2019","journal-title":"Sex Med Rev"},{"issue":"1","key":"10.1016\/j.purol.2020.04.003_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00345-016-1834-2","article-title":"Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain","volume":"35","author":"Fojecki","year":"2017","journal-title":"World J Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S116670872030107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S116670872030107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:32:48Z","timestamp":1761114768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S116670872030107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S116670872030107X"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2020.04.003","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement de la maladie de Lapeyronie par ondes de choc extracorporelles","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2020.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}